about

SENIOR EXECUTIVES

Stephen Saad (55)

Group Chief Executive

Qualifications: CA(SA), PhD (Commerce) Honoris Causa

Appointed: January 1999

Stephen is a founding shareholder of Aspen and his responsibilities extend to include strategic positioning of Aspen as a leading multinational pharmaceutical company, global transactions, geographic expansion and product diversification of Aspen in developed and emerging markets.

Further information

Gus Attridge (58)

Deputy Group Chief Executive (Finance Director)

Qualifications: CA(SA)

Appointed: January 1999

Gus is a founding shareholder of Aspen and is responsible for the strategic and financial wellbeing of the Group while also identifying and pursuing appropriate corporate opportunities and global transactions that will further benefit Aspen and its stakeholders.

Further information

Sean Capazorio (54)

Group Finance Officer

Qualifications: CA(SA)

Appointed: January 1999

Sean is responsible for all of the Group’s finance functions across Aspen’s 55 businesses and also assesses business performance and identifies business improvement opportunities.

Further information

Lorraine Hill (56)

Group Operating Officer and Responsible Pharmacist

Qualifications: BPharm

Appointed: January 1999

Lorraine is responsible for multiple operational areas of the business including strategic manufacturing, pharmaceutical affairs, new product development, strategic procurement and IT. In addition, she plays an integral role in negotiation and implementation of new business initiatives including global transactions.

Further information

Samer Kassem (45)

Chief Executive Officer, Aspen Global Incorporated CEO

Qualifications: CMA, CFM, CBM, MBA

Appointed: May 2008

Samer joined the Group with the responsibility of establishing the company to direct its global operations. He has been integrally involved in the negotiation, completion and integration of strategic acquisitions, the setting up of the Group’s global businesses as well as the trading and supply structures to support these.

Further information

Stavros Nicolaou (54)

Group Senior Executive Strategic Trade

Qualifications: B.Pharm, FPS (SA), PhD (Medicine) Honoris Causa

Appointed: January 1999

Stavros plays a pivotal role in the initiation of business development opportunities and is also key to the building and maintenance of strategic relations within industry and with all of Aspen’s stakeholders.

Further information

Carnie van der Linde (50)

Group Commercial Head

Qualifications: BTech: Dental Technology

Appointed: May 2016

Carnie is responsible for the implementation of strategy and the performance delivery of Aspen’s Commercial Pharmaceutical businesses in Europe CIS, Canada, Spanish Latin America, Brazil, Middle East North Africa and Sub-Saharan Africa.

Further information

Trevor Ziman (48)

Asia Pacific CEO

Qualifications: CA(SA)

Appointed: May 2001

Trevor is responsible for the implementation of strategy and the performance delivery of Aspen’s Commercial Pharmaceutical businesses in Australasia, China, Japan, the Philippines, Taiwan, Malaysia and Hong Kong as well as trade into the rest of the Asia Pacific region. He plays a leading role in all transactional activity in the region.

Further information